World's Best Scientists 2026 revealed!
Award Badge
Medicine
Sweden
2023

D-Index & Metrics

Medicine

D-Index
130
Citations
73312
World Ranking
2466
National Ranking
46

Research.com Recognitions

  • 2023 - Research.com Medicine in Sweden Leader Award

Overview

Olle Ringdén is affiliated with the Karolinska Institute in Sweden and has contributed extensively to the field of medicine, with a strong focus on hematology and immunology. Their research encompasses various aspects of hematopoietic stem cell transplantation and mesenchymal stem cell applications.

Their recent papers include discussions on the use of mesenchymal stromal cells to enhance hematopoietic engraftment and treat graft-versus-host disease, hemorrhages, and acute respiratory distress syndrome published in 2022 in Frontiers in Immunology. They have also engaged with studies covering hematopoietic cell transplantation techniques for acute lymphoblastic leukemia, composite outcomes after adult alternative donor hematopoietic cell transplantation, and the impact of ultrahigh resolution typing of HLA mismatches in unrelated donor transplantation. Publications also delve into systemic microinflammation and endothelial dysfunction related to dialysis therapy in uremic patients.

  • Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome (2022, Frontiers in Immunology)
  • Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia (2021, Blood Advances)
  • Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT (2020, Journal of Clinical Oncology)
  • Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation (2021, Journal of Clinical Oncology)
  • Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 Signaling (2021, Frontiers in Immunology)

Frequent co-authors collaborating with Olle Ringdén include Behnam Sadeghi, Taiga Nishihori, Bipin N. Savani, Sachiko Seo, and David A. Rizzieri. This indicates sustained research partnerships contributing to transplantation and cellular therapy.

  • Behnam Sadeghi
  • Taiga Nishihori
  • Bipin N. Savani
  • Sachiko Seo
  • David A. Rizzieri

Olle Ringdén has frequently published in journals specializing in immunology and transplantation, particularly in Frontiers in Immunology and Transplantation and Cellular Therapy, as well as Blood Advances and the Journal of Clinical Oncology. These publication venues reflect a focus on clinical and translational research within hematology and immune-related disciplines.

  • Frontiers in Immunology
  • Transplantation and Cellular Therapy
  • Blood Advances
  • Journal of Clinical Oncology
  • Stem Cells

Their primary research fields are situated within medicine, with subfields including hematology, immunology, genetics, pulmonary and respiratory medicine, and oncology. The main topics of research covered by their work include hematopoietic stem cell transplantation, mesenchymal stem cell research, acute myeloid leukemia research, immune cell function and interaction, neonatal respiratory health research, acute lymphoblastic leukemia research, and T-cell and B-cell immunology.

  • Hematology
  • Immunology
  • Genetics
  • Pulmonary and Respiratory Medicine
  • Oncology

  • Hematopoietic Stem Cell Transplantation
  • Mesenchymal stem cell research
  • Acute Myeloid Leukemia Research
  • Immune Cell Function and Interaction
  • Neonatal Respiratory Health Research
  • Acute Lymphoblastic Leukemia research
  • T-cell and B-cell Immunology

Best Publications

  • Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

    Katarina Le Blanc;Ida Rasmusson;Berit Sundberg;Cecilia Götherström

  • Graft-versus-leukemia reactions after bone marrow transplantation

    MM Horowitz;RP Gale;PM Sondel;JM Goldman

  • Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

    Katarina Le Blanc;Francesco Frassoni;Lynne Ball;Franco Locatelli

  • HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.

    Katarina Le Blanc;Charlotte Tammik;Kerstin Rosendahl;Eva Zetterberg

  • Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex.

    K. Le Blanc;L. Tammik;B. Sundberg;S. E. Haynesworth

  • Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.

    Ringdén O;Uzunel M;Rasmusson I;Remberger M

  • Immunomodulation by mesenchymal stem cells and clinical experience

    K. Le Blanc;O. Ringdén

  • Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells.

    Ida Rasmusson;Olle Ringdén;Berit Sundberg;Katarina Le Blanc

  • Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation

    Richard E. Champlin;Norbert Schmitz;Mary M. Horowitz;Bernard Chapuis

  • Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms

    Ida Rasmusson;Olle Ringdén;Berit Sundberg;Katarina Le Blanc

  • Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

    Stefan O. Ciurea;Mei Jie Zhang;Andrea A. Bacigalupo;Asad Bashey

  • Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell Transplantation

    Katarina Le Blanc;Olle Ringdén

  • Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse

    Stephanie J. Lee;John P. Klein;A. John Barrett;Olle Ringden

  • Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells.

    K. Le Blanc;H. Samuelsson;B. Gustafsson;M. Remberger

  • Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation.

    L. von Bahr;I. Batsis;G. Moll;M. Hägg

  • Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta.

    Katarina Le Blanc;Cecilia Götherström;Olle Ringdén;Moustapha Hassan

  • Mesenchymal Stem Cells Inhibit the Expression of CD25 (Interleukin‐2 Receptor) and CD38 on Phytohaemagglutinin‐Activated Lymphocytes

    K Le Blanc;I Rasmusson;C Götherström;C Seidel

  • A Randomized Trial Comparing Busulfan With Total Body Irradiation as Conditioning in Allogeneic Marrow Transplant Recipients With Leukemia: A Report From the Nordic Bone Marrow Transplantation Group

    O Ringden;T Ruutu;M Remberger;J Nikoskelainen

  • Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.

    Åsa Gustafsson;Victor Levitsky;Jie Zhi Zou;Teresa Frisan

  • Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

    Sally Arai;Mukta Arora;Tao Wang;Tao Wang;Stephen R. Spellman

Frequent Co-Authors

Per Ljungman
Per Ljungman Karolinska University Hospital
Katarina Le Blanc
Katarina Le Blanc Karolinska University Hospital
Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center
Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin
Myriam Labopin
Myriam Labopin Université Paris Cité
Mitchell S. Cairo
Mitchell S. Cairo New York Medical College
Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
Mei-Jie Zhang
Mei-Jie Zhang Medical College of Wisconsin
Stephen R. Spellman
Stephen R. Spellman Medical College of Wisconsin
Navneet S. Majhail
Navneet S. Majhail Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is a dynamic field, and there are many online degree options that can help you advance your healthcare career. If you are a registered nurse aiming to become a nurse practitioner, consider exploring rn to np programs that provide flexible pathways from an associate degree in nursing to an MSN.

Those interested in preventive health or dietary sciences may want to look at a bachelor's in nutrition online. This credential can open doors in wellness, healthcare, and research settings.

Leadership roles in healthcare management are also attainable through accredited programs. Choosing from cahme accredited online mha programs ensures your Master of Healthcare Administration is recognized for its rigor and quality.

For nurses who want to advance without added clinical requirements, rn to bsn with no clinicals options allow you to complete your education online without the need for in-person practicums. These pathways provide flexibility and convenience for working professionals.

Best Scientists Citing Olle Ringdén

Trending Scientists

Recently Published Articles